Southern Company Other Income (Expense) increased by 1.7% to -$452.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from -$460.00M to -$452.00M.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q3 '23 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | -$344.00M | -$241.00M | -$235.00M | -$220.00M | -$262.00M | -$292.00M | -$381.00M | -$460.00M | -$452.00M |
| QoQ Change | — | +29.9% | +2.5% | +6.4% | -19.1% | -11.5% | -30.5% | -20.7% | +1.7% |
| YoY Change | — | — | — | — | +23.8% | -21.2% | -30.5% | — | +1.7% |